Patten DK, Schultz BG, Berlau DJ
Drug-Drug Interaction: Carniglo-M Tablet may interact with blood thinners (warfarin, acenocoumarol), antacids, heart-related medicines (digoxin), antibiotics (doxycycline, tetracycline, ciprofloxacin, and levofloxacin), thyroid medication (levothyroxine), and osteoporosis medicine (alendronate)
But when inflammation becomes chronic or excessive , it hinders the healing process rather than supporting it
A comprehensive meta-analysis of 11 trials involving 85,373 participants demonstrated that GLP-1 RAs reduced composite kidney outcomes by 18% (HR 0.82, 95% CI 0.730.93), kidney failure by 16% (HR 0.84, 0.720.99), MACEs by 13% (HR 0.87, 0.810.93), and all-cause death by 12% (HR 0.88, 0.830.93) in participants with type 2 diabetes [94,95]
Mechanistically, BPC-157 activates VEGFR2 via the PI3K-Akt-eNOS axis to promote angiogenesis, stimulates ERK1/2 signalling to enhance fibroblast proliferation and migration, and modulates the NO system to regulate vascular tone